NAPHAZOLINE HYDROCHLORIDE

NAPHAZOLINE HYDROCHLORIDE was reported 1976 times

NAPHAZOLINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STEROID DEPENDENCE 76 0.0866
1 CATARRH 74 0.0819
2 BURNS SECOND DEGREE 76 0.0433
3 ALCOHOL POISONING 70 0.0261
4 HYPOPNOEA 74 0.0213
5 LEFT ATRIAL HYPERTROPHY 1 0.0200
6 URINE VISCOSITY INCREASED 1 0.0196
7 GLOBAL LONGITUDINAL STRAIN ABNORMAL 1 0.0182
8 AGITATION POSTOPERATIVE 1 0.0159
9 VENTRICULAR REMODELLING 1 0.0139
10 BRONCHIECTASIS 74 0.0110
11 VENA CAVA INJURY 1 0.0109
12 JOINT PROSTHESIS USER 1 0.0100
13 PAROSMIA 73 0.0097
14 RHINITIS 76 0.0094
15 GINGIVAL PAIN 74 0.0093
16 ANTI-GAD ANTIBODY POSITIVE 1 0.0089
17 CARDIAC MURMUR 75 0.0087
18 SUBSTANCE DEPENDENCE 5 0.0074
19 VITAMIN A DECREASED 1 0.0065
20 CREATININE URINE DECREASED 1 0.0063
21 GASTRIC LAVAGE 1 0.0063
22 MEAN PLATELET VOLUME DECREASED 5 0.0060
23 ABDOMINAL LYMPHADENOPATHY 5 0.0058
24 DEAFNESS PERMANENT 1 0.0051
25 HISTAMINE LEVEL INCREASED 1 0.0046
26 IMPAIRED QUALITY OF LIFE 66 0.0046
27 MONOCYTE COUNT DECREASED 5 0.0041
28 PULMONARY CONTUSION 1 0.0040
29 TUBULOINTERSTITIAL NEPHRITIS 75 0.0040
30 GASTROINTESTINAL BACTERIAL OVERGROWTH 2 0.0033
31 VAGINAL FLATULENCE 1 0.0033
32 IMPAIRED WORK ABILITY 70 0.0033
33 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
34 CYSTITIS BACTERIAL 1 0.0030
35 FREQUENT BOWEL MOVEMENTS 78 0.0029
36 STIFF PERSON SYNDROME 1 0.0029
37 SWOLLEN TONGUE 74 0.0024
38 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
39 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
40 NIGHTMARE 75 0.0022
41 GASTRITIS BACTERIAL 1 0.0021
42 SYSTEMIC LUPUS ERYTHEMATOSUS 76 0.0021
43 ACCIDENTAL OVERDOSE 75 0.0020
44 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
45 RECTAL HAEMORRHAGE 76 0.0018
46 PERFUME SENSITIVITY 1 0.0018
47 COLITIS ULCERATIVE 77 0.0017
48 TINNITUS 76 0.0017
49 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 78 0.0016
50 ABDOMINAL OPERATION 2 0.0015
51 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 1 0.0015
52 MITRAL VALVE STENOSIS 1 0.0015
53 MACULAR FIBROSIS 1 0.0015
54 SCLERAL HYPERAEMIA 1 0.0015
55 ECZEMA 75 0.0014
56 HAEMATOCHEZIA 77 0.0014
57 ANTIBODY TEST ABNORMAL 1 0.0014
58 AORTIC VALVE SCLEROSIS 1 0.0014
59 MEDICATION ERROR 74 0.0013
60 VERTIGO 81 0.0013
61 BASOPHIL COUNT INCREASED 1 0.0013
62 POST-TRAUMATIC NECK SYNDROME 1 0.0012
63 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
64 COVID-19 IMMUNISATION 1 0.0012
65 DEEP VEIN THROMBOSIS 77 0.0012
66 COLONIC ABSCESS 1 0.0012
67 ENDOCRINE OPHTHALMOPATHY 1 0.0012
68 SELF-DESTRUCTIVE BEHAVIOUR 1 0.0011
69 ABDOMINAL SEPSIS 1 0.0011
70 HEART TRANSPLANT 1 0.0011
71 TUNNEL VISION 2 0.0011
72 FOREIGN BODY IN EYE 1 0.0010
73 CORRECTIVE LENS USER 1 0.0010
74 DYSGEUSIA 73 0.0010
75 ARTHRITIS 75 0.0010
76 THYROID HORMONES INCREASED 1 0.0010
77 INSTILLATION SITE REACTION 1 0.0009
78 INTENTIONAL PRODUCT USE ISSUE 79 0.0009
79 SARCOMA 1 0.0009
80 INSTILLATION SITE IRRITATION 1 0.0008
81 BRONCHIAL HYPERREACTIVITY 1 0.0008
82 MIGRAINE 79 0.0008
83 PULMONARY EMBOLISM 76 0.0008
84 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
85 ADJUSTMENT DISORDER 1 0.0008
86 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
87 BEHAVIOUR DISORDER 4 0.0007
88 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
89 PULMONARY VALVE INCOMPETENCE 1 0.0007
90 UTERINE LEIOMYOMA 5 0.0007
91 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
92 CONJUNCTIVITIS ALLERGIC 1 0.0007
93 PALPITATIONS 78 0.0007
94 ADVERSE DRUG REACTION 59 0.0007
95 DUODENITIS 2 0.0007
96 EYE ALLERGY 1 0.0006
97 SUBSTANCE ABUSE 5 0.0006
98 SHOULDER FRACTURE 1 0.0006
99 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
100 FEMALE GENITAL TRACT FISTULA 1 0.0006
101 RIGHT VENTRICULAR FAILURE 4 0.0006
102 FAECALOMA 3 0.0005
103 OESOPHAGEAL SPASM 1 0.0005
104 IMPULSIVE BEHAVIOUR 2 0.0005
105 GINGIVAL RECESSION 1 0.0005
106 JOINT NOISE 1 0.0005
107 OSTEOLYSIS 1 0.0005
108 NEUTROPHIL COUNT INCREASED 5 0.0005
109 LIVEDO RETICULARIS 1 0.0005
110 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 86 0.0005
111 CONFUSIONAL STATE 77 0.0005
112 RENAL NEOPLASM 1 0.0005
113 ABDOMINAL DISCOMFORT 79 0.0005
114 CEREBROVASCULAR ACCIDENT 78 0.0005
115 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
116 ABDOMINAL ABSCESS 2 0.0005
117 COVID-19 79 0.0004
118 FEAR OF DEATH 1 0.0004
119 EYELID DISORDER 1 0.0004
120 LOCALISED OEDEMA 2 0.0004
121 INSTILLATION SITE PAIN 1 0.0004
122 SOMNOLENCE 79 0.0004
123 ABDOMINAL INFECTION 1 0.0004
124 PLATELET COUNT INCREASED 5 0.0004
125 RADICULOPATHY 1 0.0004
126 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
127 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
128 PRODUCT DELIVERY MECHANISM ISSUE 2 0.0004
129 PROCTITIS 1 0.0004
130 DEPRESSION 81 0.0004
131 CEREBRAL THROMBOSIS 1 0.0004
132 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
133 NEGATIVE THOUGHTS 1 0.0003
134 LYMPHOCYTE COUNT DECREASED 6 0.0003
135 CATARACT OPERATION 2 0.0003
136 EMERGENCY CARE 1 0.0003
137 PRODUCT USE IN UNAPPROVED INDICATION 80 0.0003
138 BLOOD CREATININE DECREASED 1 0.0003
139 FOREIGN BODY IN THROAT 1 0.0003
140 FOREIGN BODY SENSATION IN EYES 2 0.0003
141 ANXIETY DISORDER 1 0.0003
142 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
143 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
144 WEIGHT DECREASED 81 0.0003
145 VIITH NERVE PARALYSIS 1 0.0003
146 ENCEPHALITIS 2 0.0003
147 EAR PRURITUS 1 0.0003
148 PRODUCT CONTAMINATION 1 0.0003
149 PAIN IN EXTREMITY 82 0.0003
150 CONDITION AGGRAVATED 84 0.0003
151 MONOCYTE COUNT INCREASED 1 0.0003
152 ASTHMATIC CRISIS 1 0.0003
153 NEURODERMATITIS 1 0.0003
154 CHRONIC SINUSITIS 1 0.0003
155 EYE INFECTION 3 0.0003
156 GASTRIC INFECTION 1 0.0003
157 REHABILITATION THERAPY 1 0.0003
158 NAIL DISCOLOURATION 1 0.0003
159 HAEMATOCRIT DECREASED 5 0.0003
160 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
161 ONYCHOMADESIS 1 0.0002
162 PYREXIA 82 0.0002
163 AORTIC VALVE INCOMPETENCE 1 0.0002
164 ABNORMAL SENSATION IN EYE 1 0.0002
165 METASTATIC NEOPLASM 1 0.0002
166 OCULAR ICTERUS 1 0.0002
167 URINE OUTPUT DECREASED 2 0.0002
168 TUMOUR LYSIS SYNDROME 2 0.0002
169 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
170 SUSPECTED OFF LABEL USE 1 0.0002
171 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
172 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
173 PRODUCT DISTRIBUTION ISSUE 2 0.0002
174 RED BLOOD CELL COUNT DECREASED 6 0.0002
175 EYE INFLAMMATION 2 0.0002
176 HYPOKINESIA 3 0.0002
177 VITREOUS FLOATERS 2 0.0002
178 EXPIRED DRUG ADMINISTERED 1 0.0002
179 HEPATIC ENZYME ABNORMAL 1 0.0002
180 ERYSIPELAS 1 0.0002
181 COLORECTAL CANCER STAGE III 1 0.0002
182 WEIGHT LOSS POOR 1 0.0002
183 EAR DISCOMFORT 2 0.0002
184 C-REACTIVE PROTEIN INCREASED 7 0.0002
185 RASH 83 0.0002
186 FULL BLOOD COUNT ABNORMAL 2 0.0002
187 ERYTHEMA OF EYELID 1 0.0002
188 INTESTINAL ISCHAEMIA 1 0.0002
189 TOOTH FRACTURE 2 0.0002
190 EYE PRURITUS 6 0.0002
191 OCULAR DISCOMFORT 2 0.0002
192 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
193 PRESYNCOPE 4 0.0002
194 SMALL INTESTINAL OBSTRUCTION 2 0.0002
195 SPINAL OPERATION 2 0.0002
196 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
197 PRE-EXISTING CONDITION IMPROVED 1 0.0002
198 PHOTOPSIA 1 0.0002
199 ENTERITIS 1 0.0002
200 GLAUCOMA 3 0.0002
201 PROCTALGIA 1 0.0002
202 HAND DEFORMITY 2 0.0002
203 EYE DISORDER 5 0.0002
204 UVEITIS 2 0.0001
205 PRODUCT LABEL ISSUE 1 0.0001
206 LIMB INJURY 4 0.0001
207 ONYCHOCLASIS 1 0.0001
208 HEADACHE 89 0.0001
209 PAPULE 1 0.0001
210 RETINAL HAEMORRHAGE 1 0.0001
211 EYE IRRITATION 8 0.0001
212 PANIC REACTION 1 0.0001
213 PAIN 85 0.0001
214 PANIC ATTACK 5 0.0001
215 ARTHROPOD BITE 1 0.0001
216 SNEEZING 3 0.0001
217 HAEMODYNAMIC INSTABILITY 1 0.0001
218 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
219 ATRIOVENTRICULAR BLOCK 1 0.0001
220 BLOOD CHOLESTEROL INCREASED 6 0.0001
221 PELVIC FRACTURE 1 0.0001
222 NASAL DISCOMFORT 1 0.0001
223 ABSCESS 2 0.0001
224 SENSORY LOSS 1 0.0001
225 EYE PAIN 7 0.0001
226 ABNORMAL FAECES 1 0.0001
227 ACUTE CORONARY SYNDROME 1 0.0001
228 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
229 OFF LABEL USE 102 0.0001
230 CARDIAC OPERATION 1 0.0001
231 FATIGUE 90 0.0001
232 MENTAL DISORDER 5 0.0001
233 ORTHOSTATIC HYPOTENSION 2 0.0001
234 NAIL DISORDER 1 0.0001
235 GASTRITIS 3 0.0001
236 RESPIRATORY RATE INCREASED 1 0.0001
237 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
238 TOOTHACHE 2 0.0001
239 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
240 PNEUMONIA BACTERIAL 1 0.0001
241 RETINAL DETACHMENT 1 0.0001
242 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
243 IRON DEFICIENCY ANAEMIA 1 0.0001
244 DIVERTICULITIS 3 0.0001
245 ERYTHEMA MULTIFORME 1 0.0001
246 OCULAR HYPERAEMIA 5 0.0001
247 PRODUCT PACKAGING ISSUE 1 0.0001
248 RECALLED PRODUCT ADMINISTERED 1 0.0001
249 LOWER LIMB FRACTURE 2 0.0001
250 DYSSTASIA 3 0.0001
251 VITAMIN D DEFICIENCY 1 0.0001
252 PLASMA CELL MYELOMA 4 0.0001
253 CHOKING 2 0.0001
254 HOSPICE CARE 1 0.0001
255 INABILITY TO AFFORD MEDICATION 1 0.0001
256 UPPER LIMB FRACTURE 2 0.0001
257 VAGINAL DISCHARGE 1 0.0001
258 MOTOR DYSFUNCTION 1 0.0001
259 POOR VENOUS ACCESS 1 0.0001
260 VENTRICULAR EXTRASYSTOLES 1 0.0001
261 EYE DISCHARGE 1 0.0001
262 PULMONARY HYPERTENSION 2 0.0001
263 TENDERNESS 1 0.0001
264 PETECHIAE 1 0.0001
265 HALLUCINATION, VISUAL 2 0.0001
266 IRRITABLE BOWEL SYNDROME 2 0.0001
267 DECREASED ACTIVITY 1 0.0001
268 ASPIRATION 1 0.0001
269 IMPAIRED DRIVING ABILITY 1 0.0001
270 PRODUCT AVAILABILITY ISSUE 2 0.0001
271 DERMATITIS CONTACT 1 0.0001
272 ELECTROLYTE IMBALANCE 1 0.0001
273 EYELID OEDEMA 1 0.0001
274 VASCULITIS 1 0.0001
275 HEART RATE DECREASED 3 0.0001
276 BLOOD PRESSURE INCREASED 13 0.0001
277 COVID-19 PNEUMONIA 1 0.0001
278 NEUROPATHY PERIPHERAL 8 0.0001
279 CHOLECYSTITIS 1 0.0001
280 MACULAR DEGENERATION 1 0.0001
281 SCHIZOPHRENIA 1 0.0001
282 NEURALGIA 2 0.0001
283 DISCOMFORT 5 0.0001
284 DYSPEPSIA 8 0.0001
285 GENERALISED OEDEMA 1 0.0001
286 INJECTION SITE DISCOLOURATION 1 0.0001
287 GASTRIC CANCER 2 0.0001
288 INTRAOCULAR PRESSURE INCREASED 1 0.0001
289 GASTROINTESTINAL DISORDER 7 0.0001
290 MYDRIASIS 1 0.0001
291 ROTATOR CUFF SYNDROME 1 0.0001
292 RHINORRHOEA 5 0.0001
293 ORAL CANDIDIASIS 1 0.0001
294 DEPRESSED MOOD 4 0.0001
295 FEAR 2 0.0001
296 IMPAIRED GASTRIC EMPTYING 1 0.0001
297 CARPAL TUNNEL SYNDROME 1 0.0001
298 BLINDNESS UNILATERAL 1 0.0001
299 SLEEP DISORDER 5 0.0001
300 THERAPY INTERRUPTED 5 0.0001
301 SUBDURAL HAEMATOMA 1 0.0001
302 DRUG INEFFECTIVE 92 0.0001
303 PARAESTHESIA ORAL 1 0.0001
304 NEEDLE ISSUE 2 0.0001
305 DYSPHONIA 4 0.0001
306 CATARACT 4 0.0001
307 BLOOD POTASSIUM DECREASED 2 0.0001
308 LACRIMATION INCREASED 2 0.0001
309 OSTEOPENIA 1 0.0001
310 LYMPHOMA 1 0.0001
311 MUSCULOSKELETAL CHEST PAIN 1 0.0001
312 PRODUCT USE COMPLAINT 1 0.0001
313 CYSTITIS 2 0.0001
314 SCIATICA 1 0.0001
315 HYPOTHYROIDISM 2 0.0001
316 SENSORY DISTURBANCE 1 0.0001
317 MOVEMENT DISORDER 2 0.0001
318 MUSCLE TIGHTNESS 1 0.0001
319 BACK DISORDER 1 0.0001
320 VENTRICULAR TACHYCARDIA 1 0.0001
321 PHOTOSENSITIVITY REACTION 1 0.0001
322 DRY EYE 3 0.0001
323 CELLULITIS 3 0.0001
324 HAEMATURIA 2 0.0001
325 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
326 MUSCULOSKELETAL DISCOMFORT 1 0.0001
327 PARANOIA 1 0.0001
328 DELIRIUM 2 0.0001
329 DRUG WITHDRAWAL SYNDROME 5 0.0001
330 METASTASES TO LIVER 1 0.0001
331 HYPOXIA 2 0.0001
332 COLD SWEAT 1 0.0001
333 HEAD DISCOMFORT 1 0.0001
334 ISCHAEMIC STROKE 1 0.0001
335 THIRST 1 0.0001
336 COMPLICATION OF DEVICE REMOVAL 1 0.0001
337 CRYING 2 0.0001
338 RESTLESS LEGS SYNDROME 1 0.0001
339 END STAGE RENAL DISEASE 1 0.0001
340 AGITATION 4 0.0001
341 DYSURIA 2 0.0001
342 CONJUNCTIVITIS 1 0.0001
343 EYE SWELLING 2 0.0001
344 BACTERIAL INFECTION 1 0.0001
345 MIDDLE INSOMNIA 1 0.0001
346 FLATULENCE 3 0.0001
347 COLITIS 2 0.0001
348 BLOOD URINE PRESENT 1 0.0001
349 SLEEP APNOEA SYNDROME 1 0.0001
350 ACUTE RESPIRATORY FAILURE 1 0.0001
351 EAR PAIN 1 0.0001
352 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
353 HAEMORRHOIDS 1 0.0001
354 ORAL HERPES 1 0.0001
355 PARAESTHESIA 8 0.0001
356 HEART RATE INCREASED 5 0.0001
357 BLOOD PRESSURE ABNORMAL 1 0.0001
358 COMPLICATION OF DEVICE INSERTION 1 0.0001
359 BLINDNESS 2 0.0000
360 FEELING HOT 3 0.0000
361 HAEMOGLOBIN DECREASED 5 0.0000
362 PRODUCT PREPARATION ERROR 1 0.0000
363 OSTEOPOROSIS 2 0.0000
364 ILLNESS 5 0.0000
365 HYPERSENSITIVITY 9 0.0000
366 POLLAKIURIA 2 0.0000
367 HYPERHIDROSIS 6 0.0000
368 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
369 PRODUCT DISPENSING ERROR 1 0.0000
370 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
371 LIVER DISORDER 2 0.0000
372 TOOTH DISORDER 1 0.0000
373 RASH MACULO-PAPULAR 1 0.0000
374 THROAT IRRITATION 2 0.0000
375 VISION BLURRED 6 0.0000
376 SUICIDAL IDEATION 4 0.0000
377 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
378 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
379 CARDIAC DISORDER 4 0.0000
380 HYPERTENSION 9 0.0000
381 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
382 DISEASE RECURRENCE 2 0.0000
383 BLOOD PRESSURE FLUCTUATION 1 0.0000
384 CONSTIPATION 9 0.0000
385 MENTAL IMPAIRMENT 1 0.0000
386 ATRIAL FIBRILLATION 4 0.0000
387 INJECTION SITE URTICARIA 1 0.0000
388 EPISTAXIS 3 0.0000
389 AGGRESSION 2 0.0000
390 ABDOMINAL PAIN LOWER 1 0.0000
391 PRODUCT COMPLAINT 1 0.0000
392 PERIPHERAL SWELLING 6 0.0000
393 ABDOMINAL PAIN UPPER 8 0.0000
394 HAEMATOMA 1 0.0000
395 RESPIRATORY TRACT INFECTION 1 0.0000
396 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
397 NERVOUSNESS 2 0.0000
398 JOINT STIFFNESS 1 0.0000
399 CHEST PAIN 7 0.0000
400 EAR INFECTION 1 0.0000
401 DISTURBANCE IN ATTENTION 2 0.0000
402 THROAT TIGHTNESS 1 0.0000
403 PALLOR 1 0.0000
404 MOOD ALTERED 1 0.0000
405 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
406 PROCEDURAL PAIN 1 0.0000
407 FEELING COLD 1 0.0000
408 WEIGHT INCREASED 8 0.0000
409 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
410 INTENTIONAL DOSE OMISSION 1 0.0000
411 ANGINA PECTORIS 1 0.0000
412 HERPES ZOSTER 2 0.0000
413 ACUTE MYOCARDIAL INFARCTION 1 0.0000
414 LABORATORY TEST ABNORMAL 1 0.0000
415 INSOMNIA 9 0.0000
416 URINARY INCONTINENCE 1 0.0000
417 RESPIRATORY DISORDER 1 0.0000
418 LIMB DISCOMFORT 1 0.0000
419 VISUAL IMPAIRMENT 4 0.0000
420 PRODUCT USE ISSUE 6 0.0000
421 DRUG-INDUCED LIVER INJURY 1 0.0000
422 ANXIETY 9 0.0000
423 HEAD INJURY 1 0.0000
424 AMNESIA 2 0.0000
425 INFUSION RELATED REACTION 2 0.0000
426 VISUAL ACUITY REDUCED 1 0.0000
427 BLOOD PRESSURE DECREASED 2 0.0000
428 EXPIRED PRODUCT ADMINISTERED 1 0.0000
429 FUNGAL INFECTION 1 0.0000
430 HEPATIC ENZYME INCREASED 2 0.0000
431 URINARY TRACT INFECTION 5 0.0000
432 ABDOMINAL DISTENSION 3 0.0000
433 RASH MACULAR 1 0.0000
434 COUGH 8 0.0000
435 INFECTION 4 0.0000
436 RESTLESSNESS 1 0.0000
437 MUSCLE SPASMS 5 0.0000
438 DYSPNOEA EXERTIONAL 1 0.0000
439 ASTHMA 3 0.0000
440 HOT FLUSH 2 0.0000
441 DYSPNOEA 15 0.0000
442 MUSCULAR WEAKNESS 3 0.0000
443 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
444 DECREASED APPETITE 6 0.0000
445 BACK PAIN 6 0.0000
446 FEELING ABNORMAL 6 0.0000
447 HYPOTENSION 5 0.0000
448 DRUG DEPENDENCE 4 0.0000
449 DEVICE BREAKAGE 1 0.0000
450 OEDEMA PERIPHERAL 3 0.0000
451 DYSKINESIA 1 0.0000
452 LUNG NEOPLASM MALIGNANT 1 0.0000
453 ERYTHEMA 5 0.0000
454 TREMOR 4 0.0000
455 ARTHRALGIA 10 0.0000
456 ROAD TRAFFIC ACCIDENT 1 0.0000
457 WITHDRAWAL SYNDROME 1 0.0000
458 OSTEOARTHRITIS 1 0.0000
459 PRURITUS 9 0.0000
460 LOSS OF CONSCIOUSNESS 3 0.0000
461 DIARRHOEA 15 0.0000
462 BALANCE DISORDER 2 0.0000
463 DEVICE LEAKAGE 1 0.0000
464 DEVICE DISLOCATION 1 0.0000
465 SEPTIC SHOCK 1 0.0000
466 PRODUCT STORAGE ERROR 2 0.0000
467 MUSCULOSKELETAL STIFFNESS 2 0.0000
468 DRY SKIN 3 0.0000
469 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
470 BREAST CANCER 2 0.0000
471 ARRHYTHMIA 1 0.0000
472 DYSPHAGIA 2 0.0000
473 FALL 7 0.0000
474 COMA 1 0.0000
475 PRODUCTIVE COUGH 1 0.0000
476 CONTUSION 2 0.0000
477 INTERSTITIAL LUNG DISEASE 1 0.0000
478 MALAISE 9 0.0000
479 LUNG DISORDER 1 0.0000
480 NAUSEA 16 0.0000
481 HYPOAESTHESIA 3 0.0000
482 INFLAMMATION 1 0.0000
483 MUSCULOSKELETAL PAIN 1 0.0000
484 DERMATITIS ATOPIC 1 0.0000
485 BRADYCARDIA 1 0.0000
486 OEDEMA 1 0.0000
487 ANAPHYLACTIC REACTION 1 0.0000
488 SEPSIS 2 0.0000
489 URTICARIA 3 0.0000
490 BLISTER 1 0.0000
491 OXYGEN SATURATION DECREASED 1 0.0000
492 RHEUMATOID ARTHRITIS 2 0.0000
493 LETHARGY 1 0.0000
494 ABDOMINAL PAIN 4 0.0000
495 BONE PAIN 1 0.0000
496 CHILLS 2 0.0000
497 SURGERY 1 0.0000
498 NASAL CONGESTION 1 0.0000
499 PRODUCT DOSE OMISSION ISSUE 5 0.0000
500 DISEASE PROGRESSION 2 0.0000
501 WHEEZING 1 0.0000
502 THERAPEUTIC RESPONSE DECREASED 1 0.0000
503 ILL-DEFINED DISORDER 1 0.0000
504 PLEURAL EFFUSION 1 0.0000
505 NASOPHARYNGITIS 3 0.0000
506 PNEUMONIA 5 0.0000
507 ALOPECIA 3 0.0000
508 DEHYDRATION 2 0.0000
509 VOMITING 7 0.0000
510 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
511 INJECTION SITE REACTION 1 0.0000
512 BURNING SENSATION 1 0.0000
513 DEVICE MALFUNCTION 1 0.0000
514 MOBILITY DECREASED 1 0.0000
515 UNDERDOSE 1 0.0000
516 BRONCHITIS 1 0.0000
517 ASTHENIA 5 0.0000
518 HALLUCINATION 1 0.0000
519 ACNE 1 0.0000
520 DIABETES MELLITUS 1 0.0000
521 INJECTION SITE SWELLING 1 0.0000
522 INJECTION SITE PAIN 4 0.0000
523 HOSPITALISATION 2 0.0000
524 DRUG DOSE OMISSION BY DEVICE 1 0.0000
525 INJECTION SITE BRUISING 1 0.0000
526 CARDIAC FAILURE CONGESTIVE 1 0.0000
527 INFLUENZA LIKE ILLNESS 1 0.0000
528 CARDIAC ARREST 1 0.0000
529 DIZZINESS 6 0.0000
530 DRUG ABUSE 1 0.0000
531 SKIN EXFOLIATION 1 0.0000
532 INTENTIONAL PRODUCT MISUSE 1 0.0000
533 TACHYCARDIA 1 0.0000
534 ADVERSE EVENT 1 0.0000
535 OROPHARYNGEAL PAIN 1 0.0000
536 SWELLING 1 0.0000
537 BLOOD GLUCOSE INCREASED 2 0.0000
538 ANAEMIA 2 0.0000
539 DRUG INTOLERANCE 1 0.0000
540 FLUSHING 1 0.0000
541 CHEST DISCOMFORT 1 0.0000
542 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
543 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
544 DEATH 8 0.0000
545 OVERDOSE 2 0.0000
546 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
547 INFLUENZA 1 0.0000
548 INCORRECT DOSE ADMINISTERED 2 0.0000
549 SEIZURE 1 0.0000
550 EMOTIONAL DISTRESS 1 0.0000
551 PRODUCT QUALITY ISSUE 1 0.0000
552 MEMORY IMPAIRMENT 1 0.0000
553 ACUTE KIDNEY INJURY 1 0.0000
554 MYALGIA 1 0.0000
555 GAIT DISTURBANCE 1 0.0000